Effect of mepolizumab on chronic rhinosinusitis symptoms and nasal hypersensitivity in patients with or without nasal polyps Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020
Neutrophilic inflammation in airways in patients with nonallergic late-onset asthma with upper respiratory tract disorders Source: Annual Congress 2008 - Markers and triggers of asthma Year: 2008
Nonallergic rhinitis, sinonasal polyposis and asthma Source: Eur Respir J 2003; 22: Suppl. 45, 108s Year: 2003
Mepolizumab reduces nasal symptoms in asthmatic patients with chronic rhino-sinusitis and nasal polyposis: a 12 months real-life study Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020
Pathophysiology of airway hyperresponsiveness in patients with nasal polyposis Source: Annual Congress 2011 - Phenotyping airway diseases Year: 2011
Impact of mepolizumab in severe asthma with nasal polyps Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021
Perception of nocturnal nasal obstruction in chronic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 565s Year: 2005
Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction Source: Eur Respir J 2002; 20: Suppl. 38, 505s Year: 2002
Mepolizumab in the treatment of severe asthma with nasal polyposis: real-life study Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
Nocturnal respiratory symptoms in patients with chronic rhinosinusitis Source: Annual Congress 2009 - Diagnostic aspects in obstructive sleep apnoea Year: 2009
Nasal polyposis, analgesics intolerance and asthma Source: Eur Respir J 2001; 18: Suppl. 33, 428s Year: 2001
Treatment of inflammatory diseases of the nose Source: ISSN=1025-448x, ISBN=1-904097-19-21, page=165 Year: 2001
The impact of targeted therapy in children with uncontrolled allergic persistent severe asthma and nasal polyps Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities Year: 2017
Snoring is related to recurrent wheezing, rhinitis and dyspnea but not to type-1 allergy or bronchial hyperresponsiveness Source: Eur Respir J 2004; 24: Suppl. 48, 503s Year: 2004
Effect of anti-IL5 treatment on symptoms of chronic rhinosinusitis, otitis and hearing loss in patients with severe eosinophilic asthma Source: International Congress 2019 – Clinical approach to asthma management Year: 2019
Differential treatment response to mepolizumab in severe eosinophilic asthma with nasal polyps Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020
Nasal mucosa biopsy in patients with severe bronchial asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Treatment of bronchial asthma and wheezing disorders: acute Source: ERS Skills Course 2016 Year: 2016
Treatment of bronchial asthma and wheezing disorders: chronic Source: ERS Skills Course 2016 Year: 2016
Type 2 inflammation-related comorbidities among patients with asthma, chronic rhinosinusitis with nasal polyps, and atopic dermatitis Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020